News > India lifts export ban on hydroxychloroquine

India lifts export ban on hydroxychloroquine

India has lifted export ban on hydroxychloroquine, the anti-malarial drug touted by the U.S. as a potential "game changer" in the fight against COVID-19. British scientists last week halted a major trial after it found that the drug was "useless" at treating COVID patients. India, a leading exporter of generic medicines across the world, banned the export of the drug and its formulations in March and then eased some of these restrictions in April and shipped 50 million tablets of the drug to the United States that month.